Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Cynthia Caracta, MD FCCP
Glenmark Pharmaceuticals S.A.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
25 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Glenmark Investigational Site 23
Andalusia, Alabama, United States
- Glenmark Investigational Site 12
Phoenix, Arizona, United States
- Glenmark Investigational Site 14
Tempe, Arizona, United States
- Glenmark Investigational Site 17
Fullerton, California, United States
- Glenmark Investigational Site 19
Edgewater, Florida, United States
- Glenmark Investigational Site 16
Miami, Florida, United States
- Glenmark Investigational Site 24
Miami, Florida, United States
- Glenmark Investigational Site 10
Miami Lakes, Florida, United States
- Glenmark Investigational Site 6
Orlando, Florida, United States
- Glenmark Investigational Site 20
Ormond Beach, Florida, United States
- Glenmark Investigational Site 21
Vero Beach, Florida, United States
- Glenmark Investigational Site 13
Winter Park, Florida, United States
- Glenmark Investigational Site 18
Las Vegas, Nevada, United States
- Glenmark Investigational Site 9
Charlotte, North Carolina, United States
- Glenmark Investigational Site 22
Columbus, Ohio, United States
- Glenmark Investigational Site 5
Columbus, Ohio, United States
- Glenmark Investigational Site 8
Dublin, Ohio, United States
- Glenmark Investigational Site 11
Medford, Oregon, United States
- Glenmark Investigational Site 3
Easley, South Carolina, United States
- Glenmark Investigational Site 2
Greenville, South Carolina, United States
- Glenmark Investigational Site 4
Greenville, South Carolina, United States
- Glenmark Investigational Site 1
Rock Hill, South Carolina, United States
- Glenmark Investigational Site 15
Spartanburg, South Carolina, United States
- Glenmark Investigational Site 7
Spartanburg, South Carolina, United States
- Glenmark Investigational Site 25
Tomball, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 24 Mar 2017
- Primary completion
- 31 Jul 2017
- Completion
- 31 Jul 2017
- Last update posted
- 1 Aug 2019
- Registered enrollment
- 155
- Registry id
- NCT03118765
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.